JYNT stock forecast
Our latest prediction for The Joint Corp. (United States)'s stock price was made on the June 29, 2018 when the stock price was at 8.18$.
In the short term (2weeks), JYNT's stock price should underperform the market by -0.05%. During that period the price should oscillate between -6.55% and +8.09%.
In the medium term (3months), JYNT's stock price should outperform the market by 1.35%. During that period the price should oscillate between -15.16% and +23.70%.Get email alerts
About The Joint Corp. (United States)
The Joint Corp. (United States) engages in the development, ownership, operation, support and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment comprises of the operating activities of the company owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.
At the moment the company generates 30M USD in revenues.
On its last earning announcement, the company reported a loss of -0.05$ per share.
The book value per share is 0.10$
Three months stock forecastJune 29, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|